The organization announced the winners of the 2016 awards at a dinner on Sept. 13 in Washington DC.
On Sept. 13, 2016, Pharmaceutical Research and Manufacturers of America (PhRMA) announced the recipients of the 2016 Research & Hope Awards. This year, PhRMA recognized patient advocates and researchers for their efforts to advance the treatment and care of patients with autoimmune diseases. The organization was joined by 22 patient and community health organizations at a dinner in Washington DC to honor the award winners.
For more information on the awards recipients, visit PhRMA’s website. Recipients of the PhRMA 2016 Research & Hope Awards are:
The PhRMA Research & Hope Award for Biopharmaceutical Industry ResearchJohn Medich, PhD, vice-president, immunology clinical development, AbbVie
The PhRMA Research & Hope Award for Community ChampionMila Ferrer, community and social media manager, Hispanic market, Diabetes Hands Foundation
The PhRMA Research & Hope Award for Excellence in Advocacy & ActivismVirginia T. Ladd, president and executive director, American Autoimmune Related Diseases Association, Inc.
The PhRMA Research & Hope Award for Government ResearchLisa G. Rider, MD, deputy chief, environmental autoimmunity group, National Institute of Environmental Health Sciences, National Institutes of Health
The PhRMA Research & Hope Award for Nonprofit ResearchJoan T. Merrill, MD, chief advisor, clinical development, Lupus Foundation of America
The PhRMA Research & Hope Award for Visibility & ProgressParker Lentini, patient and advocate.
Source: PhRMA
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.